131 related articles for article (PubMed ID: 22126379)
1. Immunohistochemical, molecular, and clinicopathological analyses of urothelial carcinoma, micropapillary variant.
Ishii S; Ohbu M; Toomine Y; Nishimura Y; Hattori M; Yokoyama M; Toyonaga M; Kakinuma H; Matsumoto K
Pathol Int; 2011 Dec; 61(12):723-30. PubMed ID: 22126379
[TBL] [Abstract][Full Text] [Related]
2. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
3. Invasive micropapillary urothelial carcinoma of the bladder.
Lopez-Beltran A; Montironi R; Blanca A; Cheng L
Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
[TBL] [Abstract][Full Text] [Related]
5. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases.
Lin O; Cardillo M; Dalbagni G; Linkov I; Hutchinson B; Reuter VE
Mod Pathol; 2003 Dec; 16(12):1289-98. PubMed ID: 14681330
[TBL] [Abstract][Full Text] [Related]
6. Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases.
Compérat E; Roupret M; Yaxley J; Reynolds J; Varinot J; Ouzaïd I; Cussenot O; Samaratunga H
Pathology; 2010 Dec; 42(7):650-4. PubMed ID: 21080874
[TBL] [Abstract][Full Text] [Related]
7. The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion--the prognostic contribution of related molecular markers.
Afonso J; Santos LL; Amaro T; Lobo F; Longatto-Filho A
Histopathology; 2009 Nov; 55(5):514-24. PubMed ID: 19912357
[TBL] [Abstract][Full Text] [Related]
8. The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma.
Lin X; Zhu B; Villa C; Zhong M; Kundu S; Rohan SM; Yang XJ
Hum Pathol; 2014 Sep; 45(9):1824-9. PubMed ID: 24993315
[TBL] [Abstract][Full Text] [Related]
9. Gastric micropapillary carcinoma: A distinct subtype with a significantly worse prognosis in TNM stages I and II.
Eom DW; Kang GH; Han SH; Cheon GJ; Han KH; Oh HS; Kim JH; Jang HJ; Hong SM
Am J Surg Pathol; 2011 Jan; 35(1):84-91. PubMed ID: 21164291
[TBL] [Abstract][Full Text] [Related]
10. Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma.
Hayashi T; Sentani K; Oue N; Anami K; Sakamoto N; Ohara S; Teishima J; Noguchi T; Nakayama H; Taniyama K; Matsubara A; Yasui W
Histopathology; 2011 Oct; 59(4):710-21. PubMed ID: 22014052
[TBL] [Abstract][Full Text] [Related]
11. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
[TBL] [Abstract][Full Text] [Related]
12. CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa.
Palmeira C; Lameiras C; Amaro T; Lima L; Koch A; Lopes C; Oliveira PA; Santos L
Urol Oncol; 2011; 29(2):205-11. PubMed ID: 19854077
[TBL] [Abstract][Full Text] [Related]
13. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
[TBL] [Abstract][Full Text] [Related]
15. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
Behzatoğlu K; Yörükoğlu K; Demir H; Bal N
Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766
[TBL] [Abstract][Full Text] [Related]
16. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder.
Tong GX; Yee H; Chiriboga L; Hernandez O; Waisman J
Hum Pathol; 2005 Jul; 36(7):741-6. PubMed ID: 16084942
[TBL] [Abstract][Full Text] [Related]
17. Micropapillary urothelial carcinoma: an aggressive variant of urothelial carcinoma.
Loghin A; Chibelean C; Orsolya M; Nechifor-Boilă A; Nechifor-Boilă A; Borda A
Rom J Morphol Embryol; 2014; 55(3):939-45. PubMed ID: 25329124
[TBL] [Abstract][Full Text] [Related]
18. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
20. The role of nm23-H1 in the progression of transitional cell bladder cancer.
Chow NH; Liu HS; Chan SH
Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
